IAG Wealth Partners’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.87K Hold
1,880
﹤0.01% 423
2026
Q1
$5.77K Hold
1,880
﹤0.01% 416
2025
Q4
$6.69K Hold
1,880
﹤0.01% 390
2025
Q3
$16.7K Hold
1,880
﹤0.01% 322
2025
Q2
$17.3K Hold
1,880
﹤0.01% 293
2025
Q1
$16.1K Hold
1,880
﹤0.01% 291
2024
Q4
$20.2K Hold
1,880
﹤0.01% 284
2024
Q3
$10.7K Hold
1,880
﹤0.01% 333
2024
Q2
$7.93K Hold
1,880
﹤0.01% 355
2024
Q1
$9.57K Buy
+1,880
New +$10.6K ﹤0.01% 318

Other funds holding AVXL

IAG Wealth Partners's AVXL Position: Q2 2026 in Review

IAG Wealth Partners held its Anavex Life Sciences (AVXL) position steady in Q2 2026 at 1,880 shares worth $4.87K. The position accounts for ﹤0.01% of the portfolio, ranked #423.

IAG Wealth Partners first reported a position in AVXL in Q1 2024 and has held it in 10 quarters since. The position peaked at $20.2K in Q4 2024. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • IAG Wealth Partners held 1,880 shares of Anavex Life Sciences worth $4.87K as of Q2 2026.
  • IAG Wealth Partners left its Anavex Life Sciences share count unchanged in Q2 2026.
  • Anavex Life Sciences made up ﹤0.01% of IAG Wealth Partners's portfolio in Q2 2026, its #423 holding.
  • IAG Wealth Partners first reported a position in Anavex Life Sciences in Q1 2024 and has held it in 10 quarters since.
  • IAG Wealth Partners's Anavex Life Sciences position peaked at $20.2K in Q4 2024.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on IAG Wealth Partners's 13F filing for Q2 2026, filed 6 Aug 2026.